GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Protect Pharmaceutical Corp (OTCPK:PRTT) » Definitions » Gross Margin %

Protect Pharmaceutical (Protect Pharmaceutical) Gross Margin % : 0.00% (As of Jun. 2018)


View and export this data going back to 2006. Start your Free Trial

What is Protect Pharmaceutical Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Protect Pharmaceutical's Gross Profit for the three months ended in Jun. 2018 was $0.00 Mil. Protect Pharmaceutical's Revenue for the three months ended in Jun. 2018 was $0.00 Mil. Therefore, Protect Pharmaceutical's Gross Margin % for the quarter that ended in Jun. 2018 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Protect Pharmaceutical's Gross Margin % or its related term are showing as below:


PRTT's Gross Margin % is not ranked *
in the Conglomerates industry.
Industry Median: 25.03
* Ranked among companies with meaningful Gross Margin % only.

Protect Pharmaceutical had a gross margin of N/A% for the quarter that ended in Jun. 2018 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Protect Pharmaceutical was 0.00% per year.


Protect Pharmaceutical Gross Margin % Historical Data

The historical data trend for Protect Pharmaceutical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protect Pharmaceutical Gross Margin % Chart

Protect Pharmaceutical Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Gross Margin %
Get a 7-Day Free Trial Premium Member Only - - - - -

Protect Pharmaceutical Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Protect Pharmaceutical's Gross Margin %

For the Conglomerates subindustry, Protect Pharmaceutical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protect Pharmaceutical's Gross Margin % Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's Gross Margin % falls into.



Protect Pharmaceutical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Protect Pharmaceutical's Gross Margin for the fiscal year that ended in Dec. 2017 is calculated as

Gross Margin % (A: Dec. 2017 )=Gross Profit (A: Dec. 2017 ) / Revenue (A: Dec. 2017 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Protect Pharmaceutical's Gross Margin for the quarter that ended in Jun. 2018 is calculated as


Gross Margin % (Q: Jun. 2018 )=Gross Profit (Q: Jun. 2018 ) / Revenue (Q: Jun. 2018 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Protect Pharmaceutical  (OTCPK:PRTT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Protect Pharmaceutical had a gross margin of N/A% for the quarter that ended in Jun. 2018 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Protect Pharmaceutical Gross Margin % Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Protect Pharmaceutical (Protect Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
12465 South Street, Suite 240, Draper, UT, USA, 84020
Protect Pharmaceutical Corp has an organic solution to soil and crop protection, annual growth, and natural restoration upon the completion of crop cycles. The company uses its products to revitalize farming soil, produce organic, toxin-free crops, and meet the increasing global demand for agricultural sustainability initiatives.